Ignite Creation Date:
2024-05-06 @ 2:21 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02023606
Status:
COMPLETED
Last Update Posted:
2016-05-13
First Post:
2013-12-17
Brief Title:
Phase I Study to Assess the Absorption Metabolism and Excretion of 14C Labeled SPN-810M
Sponsor:
Supernus Pharmaceuticals Inc
Organization:
Supernus Pharmaceuticals Inc
Study Overview
Official Title:
An Open-Label Single-Dose Mass-Balance Study to Assess the Absorption Metabolism and Excretion AME of 14C Labeled SPN-810M in Healthy Adult Male Volunteers
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An Open-Label Single-Dose Mass-Balance Study to Assess the Absorption Metabolism and Excretion of Radio Labeled SPN-810M in Healthy Adult Male Volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None